Cardlytics Inc
NASDAQ:CDLX
Cardlytics Inc
NASDAQ:CDLX
Price:
0.91465
USD
-2.88%
Market Cap:
$49.4m
Balance Sheet
Balance Sheet Decomposition
Cardlytics Inc
Cardlytics Inc
Balance Sheet Decomposition is not available for
Cardlytics Inc
Cardlytics Inc
Balance Sheet
Cardlytics Inc
Cardlytics Inc
Currency: USD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
27
|
23
|
21
|
40
|
105
|
293
|
234
|
122
|
92
|
66
|
|
| Cash Equivalents |
27
|
23
|
21
|
40
|
105
|
293
|
234
|
122
|
92
|
66
|
|
| Total Receivables |
39
|
44
|
51
|
61
|
85
|
87
|
117
|
120
|
126
|
107
|
|
| Accounts Receivables |
37
|
42
|
48
|
58
|
82
|
81
|
111
|
116
|
121
|
103
|
|
| Other Receivables |
2
|
2
|
3
|
2
|
4
|
5
|
6
|
5
|
5
|
4
|
|
| Other Current Assets |
2
|
2
|
2
|
24
|
6
|
6
|
8
|
8
|
6
|
5
|
|
| Total Current Assets |
68
|
68
|
75
|
124
|
196
|
386
|
359
|
250
|
224
|
178
|
|
| PP&E Net |
10
|
8
|
7
|
10
|
14
|
25
|
22
|
13
|
11
|
9
|
|
| PP&E Gross |
10
|
8
|
7
|
10
|
14
|
25
|
22
|
13
|
11
|
9
|
|
| Accumulated Depreciation |
5
|
7
|
11
|
14
|
18
|
22
|
27
|
30
|
33
|
10
|
|
| Intangible Assets |
1
|
1
|
1
|
2
|
4
|
7
|
139
|
73
|
60
|
45
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
743
|
353
|
277
|
159
|
|
| Other Long-Term Assets |
4
|
10
|
18
|
17
|
10
|
6
|
2
|
3
|
3
|
2
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
743
|
353
|
277
|
159
|
|
| Total Assets |
82
N/A
|
87
+6%
|
101
+16%
|
154
+53%
|
224
+46%
|
423
+88%
|
1 264
+199%
|
691
-45%
|
574
-17%
|
393
-32%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
11
|
2
|
2
|
2
|
1
|
1
|
5
|
4
|
4
|
4
|
|
| Accrued Liabilities |
11
|
8
|
9
|
10
|
14
|
18
|
38
|
37
|
23
|
15
|
|
| Short-Term Debt |
22
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
46
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
23
|
30
|
31
|
40
|
63
|
62
|
285
|
208
|
143
|
85
|
|
| Total Current Liabilities |
67
|
40
|
42
|
52
|
78
|
81
|
327
|
249
|
171
|
149
|
|
| Long-Term Debt |
13
|
114
|
67
|
47
|
0
|
174
|
184
|
226
|
258
|
168
|
|
| Deferred Income Tax |
4
|
4
|
4
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
10
|
61
|
5
|
11
|
6
|
|
| Total Liabilities |
84
N/A
|
158
+87%
|
113
-28%
|
102
-10%
|
81
-20%
|
265
+228%
|
573
+116%
|
480
-16%
|
439
-8%
|
323
-27%
|
|
| Equity | |||||||||||
| Common Stock |
160
|
146
|
196
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
173
|
249
|
268
|
322
|
339
|
394
|
523
|
977
|
1 111
|
1 301
|
|
| Additional Paid In Capital |
10
|
30
|
59
|
372
|
481
|
551
|
1 213
|
1 183
|
1 244
|
1 367
|
|
| Other Equity |
1
|
2
|
1
|
2
|
1
|
0
|
1
|
6
|
2
|
4
|
|
| Total Equity |
2
N/A
|
71
-3 271%
|
12
+83%
|
52
N/A
|
143
+176%
|
157
+10%
|
691
+339%
|
212
-69%
|
135
-36%
|
70
-48%
|
|
| Total Liabilities & Equity |
82
N/A
|
87
+6%
|
101
+16%
|
154
+53%
|
224
+46%
|
423
+88%
|
1 264
+199%
|
691
-45%
|
574
-17%
|
393
-32%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
20
|
20
|
20
|
23
|
27
|
28
|
34
|
34
|
40
|
51
|
|
| Preferred Shares Outstanding |
0
|
0
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
